Mechanism: Semaglutide works primarily through appetite suppression by acting on GLP-1 receptors in the brain and gut
Nature Reviews Endocrinology, 9 (6), 357-365
Ban K, Kim KH, Cho CK, Sauv M, Diamandis EP, Backx PH, Drucker DJ, Husain M: Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor
According to a 2014 review published in The Lancet: Diabetes & Endocrinology , loss of muscle mass and strength is an important risk factor for accelerating rates of physical disability, hospitalization, and death in the older population, and is associated with the progressive health implications of diabetes, obesity, hyperthyroidism, hypercortisolism, vitamin D deficiency, osteoporosis, rheumatoid arthritis, COPD, congestive heart failure, renal disease and more